Quest PharmaTech Inc. QPT

TSXV · Canada · Commercial Services

CAD 0.02500.00 (0.00%)

Market closed· Sep 24, 2026, 1:30 PM UTC· CAD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Quest PharmaTech Inc. QPT

TSXV · Canada · Commercial Services

CAD 0.02500.00 (0.00%)

Market closed· Sep 24, 2026, 1:30 PM UTC· CAD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

0.00% · 6MFull-screen chart

Open CAD 0.0300High CAD 0.0300Low CAD 0.0300Close CAD 0.0300Volume 0

Oct 1, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: CAD 0.0250
Day range: CAD 0.0250 – CAD 0.0250
52-week range: CAD 0.0200 – CAD 0.0500
Volume: 16.00K
Market cap: CAD 4.23M
P/E (last fiscal year): 0.8
Avg. volume (1Y): 26.74K

Performance

1 week

0.00%

1 month

+50.00%

3 months

0.00%

6 months

0.00%

Year to date

-25.00%

1 year

-40.00%

Total return, dividends included.

Company profile

Sector: Commercial Services
Industry: Miscellaneous Commercial Services
Country: Canada
Exchange: TSXV
Shares outstanding: 169.13M
ISIN: CA74836M1068
Beta: -0.02

Technical view

Mixed

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceSep 25, 2026

Quest PharmaTech Announces Change of Chief Executive Officer

EDMONTON, Alberta, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary technologies, today announces the change of its Chief Executive Officer (CEO). Effective November 23, 2026, Dr. Madi Madiyalakan will be retiring from his position as Quest’s CEO. Dr. Madiyalakan has been the CEO of Quest since August 2006. Mr. Jeff

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.